Martingale Asset Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$834K Buy
+14,209
New +$596K 0.02% 568
2025
Q3
Sell
-10,853
Closed -$293K 848
2025
Q2
$293K Sell
10,853
-7,600
-41% -$220K 0.01% 708
2025
Q1
$547K Sell
18,453
-5,603
-23% -$214K 0.01% 584
2024
Q4
$953K Sell
24,056
-2,498
-9% -$94.6K 0.02% 485
2024
Q3
$904K Sell
26,554
-3,551
-12% -$99.9K 0.02% 485
2024
Q2
$652K Buy
30,105
+6,504
+28% +$137K 0.01% 545
2024
Q1
$523K Buy
23,601
+9,428
+67% +$230K 0.01% 607
2023
Q4
$390K Sell
14,173
-98
-0.7% -$2.37K 0.01% 658
2023
Q3
$319K Sell
14,271
-6
-0% -$154 0.01% 678
2023
Q2
$364K Buy
14,277
+3,002
+27% +$72.8K 0.01% 665
2023
Q1
$251K Buy
11,275
+1,112
+11% +$26.9K ﹤0.01% 735
2022
Q4
$241K Buy
+10,163
New +$236K ﹤0.01% 760

Other funds holding VCYT

Martingale Asset Management's VCYT Position: Q2 2026 in Review

Martingale Asset Management opened a new position in Veracyte (VCYT) in Q2 2026: 14,209 shares worth $834K. The stake represents 0.02% of the portfolio and ranks #568 among its holdings. This is a return to the name: Martingale Asset Management previously reported a position in VCYT as recently as Q2 2025.

Martingale Asset Management first reported a position in VCYT in Q4 2022 and has held it in 12 quarters since. The position peaked at $953K in Q4 2024. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Martingale Asset Management held 14,209 shares of Veracyte worth $834K as of Q2 2026.
  • Veracyte was a new Martingale Asset Management position in Q2 2026.
  • Veracyte made up 0.02% of Martingale Asset Management's portfolio in Q2 2026, its #568 holding.
  • Martingale Asset Management first reported a position in Veracyte in Q4 2022 and has held it in 12 quarters since.
  • Martingale Asset Management's Veracyte position peaked at $953K in Q4 2024.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Martingale Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.